全文获取类型
收费全文 | 978篇 |
免费 | 63篇 |
国内免费 | 4篇 |
专业分类
耳鼻咽喉 | 5篇 |
儿科学 | 26篇 |
妇产科学 | 31篇 |
基础医学 | 110篇 |
口腔科学 | 44篇 |
临床医学 | 111篇 |
内科学 | 207篇 |
皮肤病学 | 35篇 |
神经病学 | 81篇 |
特种医学 | 20篇 |
外科学 | 97篇 |
综合类 | 3篇 |
预防医学 | 66篇 |
眼科学 | 33篇 |
药学 | 73篇 |
中国医学 | 7篇 |
肿瘤学 | 96篇 |
出版年
2024年 | 1篇 |
2023年 | 12篇 |
2022年 | 25篇 |
2021年 | 50篇 |
2020年 | 26篇 |
2019年 | 30篇 |
2018年 | 37篇 |
2017年 | 27篇 |
2016年 | 34篇 |
2015年 | 23篇 |
2014年 | 40篇 |
2013年 | 58篇 |
2012年 | 78篇 |
2011年 | 92篇 |
2010年 | 42篇 |
2009年 | 42篇 |
2008年 | 65篇 |
2007年 | 58篇 |
2006年 | 84篇 |
2005年 | 55篇 |
2004年 | 58篇 |
2003年 | 39篇 |
2002年 | 29篇 |
2001年 | 2篇 |
2000年 | 2篇 |
1999年 | 5篇 |
1998年 | 6篇 |
1997年 | 4篇 |
1996年 | 6篇 |
1995年 | 4篇 |
1994年 | 2篇 |
1993年 | 1篇 |
1992年 | 1篇 |
1991年 | 1篇 |
1988年 | 2篇 |
1986年 | 1篇 |
1985年 | 1篇 |
1972年 | 1篇 |
1966年 | 1篇 |
排序方式: 共有1045条查询结果,搜索用时 0 毫秒
101.
Dr. V. Heppert D. Kotsougiani L. Kolios Prof. Dr. M. Lehnhardt 《Trauma und Berufskrankheit》2012,14(2):128-136
The title of this paper describes the problem of decision-making in these problematic medical cases and despite all progress in the field of microsurgical techniques and bone reconstruction there is still no really certain solution available apart from in some exceptional cases. The possibilities for bone reconstruction are decisively improved by callus distraction but the combination of soft tissue problems and bone defects is still a challenge for the treating physician. The age of the patient, individual risk factors and psychosocial problems should be integrated in the decision which is a team approach for the first decision as soon as possible. The decision should be discussed extensively with the patient who, after extensive consultation and informed consent, makes the final decision. 相似文献
102.
103.
104.
105.
Korkolis DP Apostolaki K Aggeli C Plataniotis G Gontikakis E Volanaki D Sebastiadou M Dimitroulopoulos D Xinopoulos D Zografos GN Vassilopoulos PP 《World journal of gastroenterology : WJG》2008,14(40):6261-6264
A case of a successfully treated solitary fibrous tumor (SFT) of the liver is reported. An 82-year-old female presented with left upper abdominal discomfort, a firm mass on palpation, and imaging studies revealed a large tumor, 15 cm in diameter, arising from the left lobe of the liver. A formal left hepatectomy was performed. Microscopic evaluation showed spindle and fibroblast-like cells within the collagenous stroma. Immunohistochemistry disclosed diffuse CD34 and positive vimentin, supporting the diagnosis of a benign SFT. The patient remained well 21 months after surgery. SFT of the liver is a very rare neoplasm of mesenchymal origin. In most cases it is a benign lesion, although some may have malignant histological features and recur locally or metastasize. With less than 30 reported cases in the literature, little can be said regarding its natural history or the benefitsof adjuvant radiochemotherapy. Complete surgical resection remains the cornerstone of its treatment. 相似文献
106.
Anagnostopoulos A Galani E Gika D Sotou D Evangelopoulou A Dimopoulos MA 《Annals of hematology》2004,83(10):658-660
The aim of this study was to assess the effect of systemic chemotherapy on the monoclonal protein levels of patients with solid tumors who also have a monoclonal gammopathy of undetermined significance (MGUS). All patients with solid tumors who were referred to our department for consideration of systemic chemotherapy were evaluated with serum protein electrophoresis (SPEP) for the presence of MGUS. When MGUS was confirmed with immunofixation, serial SPEP was performed during and after completion of chemotherapy. Over a 6-year period, 21 patients with solid tumors and MGUS were prospectively identified and assessed. At least 50% reduction of serum monoclonal protein was noted in 4 of 11 patients treated with paclitaxel or docetaxel with a platinum analogue and in 5 of 7 patients who received an irinotecan-containing regimen. Our data indicate that in MGUS patients treated with irinotecan-containing chemotherapy regimens, a high incidence of reduction in their monoclonal protein levels is observed. Since topotecan, another topoisomerase I inhibitor, has some activity in multiple myeloma, further evaluation of irinotecan may be warranted. Evaluation of larger numbers of MGUS patients treated with chemotherapy for their underlying malignancy may help identify in vivo potentially active agents and regimens for patients with overt myeloma. 相似文献
107.
Malidelis YI Panayotacopoulou MT van Heerikhuize JJ Unmehopa UA Kontostavlaki DP Swaab DF 《Neuroendocrinology》2005,82(2):63-69
Dysfunction in water intake and metabolism has frequently been reported in schizophrenia. The general population of schizophrenics under neuroleptic treatment secretes lower amounts of vasopressin than controls at comparable values of plasma osmolality. The purpose of the present study was to investigate the synthetic activity of vasopressin neurons of the dorsolateral supraoptic nucleus in schizophrenia on postmortem material using a battery of histochemical activity markers. Our material consisted of formalin-fixed and paraffin-embedded hypothalami from 5 schizophrenic patients under neuroleptic treatment and from 5 matched controls, obtained from The Netherlands' Brain Bank. DSM-III or DSM-IV criteria were used for the clinical diagnosis. The histochemical markers used to study the neuronal activity of the magnocellular vasopressin-synthesizing neurons were: cell size, size of the Golgi apparatus, and expression of vasopressin and tyrosine hydroxylase mRNA by in situ hybridization. Morphometric evaluation and statistical analysis (Mann-Whitney U test) were performed. Our results showed no statistically significant differences in any of the neuronal activity markers between schizophrenic patients and controls. Therefore, the neurosecretory activity of vasopressin neurons of the dorsolateral part of the supraoptic nucleus does not appear to be changed in schizophrenic patients under medication. Since our sample did not include patients with reported polydipsia or hyponatremia, prospective investigation is needed to evaluate the above-mentioned neuronal activity markers in such a particular subgroup of schizophrenic patients. 相似文献
108.
Dietary soy containing phytoestrogens does not activate the hemostatic system in postmenopausal women 总被引:4,自引:0,他引:4
Teede HJ Dalais FS Kotsopoulos D McGrath BP Malan E Gan TE Peverill RE 《The Journal of clinical endocrinology and metabolism》2005,90(4):1936-1941
The soybean is rich in isoflavone phytoestrogens, which are ligands for estrogen receptors, but it is unknown whether soy/phytoestrogens have similar procoagulant effects to estrogen. In this randomized double-blind trial, 40 healthy postmenopausal women of age 50-75 yr received soy protein isolate (40 g soy protein, 118 mg isoflavones) (n = 19) or casein placebo (n = 21). Plasma markers of coagulation, fibrinolysis, and endothelial dysfunction were measured at baseline and 3 months. The baseline characteristics of the two groups were similar. Compared with casein placebo, soy decreased triglycerides (P < 0.005) and low-density lipoprotein/high-density lipoprotein ratio (P < 0.001) and increased lipoprotein (a) (P < 0.05). Activity of coagulation factor VII (VIIc) decreased similarly in both groups (P < 0.005). Prothrombin fragments 1 + 2 (a marker of thrombin generation) decreased in the soy group (P < 0.005), but the change was not different from the casein group. There was no effect of soy on soluble fibrin (a marker of fibrin production), plasminogen activator inhibitor-1 (a marker of fibrinolytic inhibitory potential), D-dimer (a marker of fibrin turnover), or von Willebrand factor (a marker of endothelial damage). In conclusion, the results of the current study do not support biologically significant estrogenic effects of soy/phytoestrogens on coagulation, fibrinolysis, or endothelial function. 相似文献
109.
110.
George D. Kymionis Dimitrios G. Mikropoulos Dimitra M. Portaliou Kostantinos G. Boboridis Irini C. Voudouragkaki Nikolaos D. Dragoumis Anastasios G. P. Konstas 《Advances in therapy》2014,31(5):494-511
Lamellar (anterior and posterior) keratoplasty entails the surgical replacement of diseased-only corneal tissue, while healthy host corneal tissue is preserved. Selective keratoplasty offers several advantages in comparison to penetrating keratoplasty such as a lower rate of graft rejection, less endothelial cell loss, faster/superior visual rehabilitation and enhanced resistance to closed injury. The surgical approach of “partial corneal transplantation” may be divided into anterior and posterior: techniques including superficial and deep anterior lamellar keratoplasty (SALK and DALK, respectively) and endothelial keratoplasty as well as Descemet stripping automated endothelial keratoplasty (DSAEK) and Descemet membrane endothelial keratoplasty (DMEK). These novel surgical procedures are rapidly becoming the preferred therapy option for specific corneal dysfunctions involving the corneal stroma (SALK, DALK), or corneal endothelium (DSAEK, DMEK). During the past decade, the continuing advancement of surgical techniques and the development of innovative surgical instruments have significantly enhanced corneal transplantation. Lamellar keratoplasty techniques facilitate corneal surgery, provide patients with superior outcomes and can successfully restore vision in corneal-related blindness. Nevertheless, more long-term evidence is needed to better evaluate these promising new techniques. 相似文献